Whole-exome sequencing (WES) revealed a heterozygous variant in the IGF2BP2 gene (c.248A>G, p. Lys83Thr; rs4402960), a risk locus for T2D. This evidence concerns the gene IGF2BP2 and type 2 diabetes mellitus.